Page 579 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 579
CHAPTER 25 Tumors of the Skeletal System 557
92. Barger AM, Fan TM, de Lorimier LP, et al.: Expression of receptor 114. Boston SE, Ehrhart NP, Dernell WS, et al.: Evaluation of survival
activator of nuclear factor kappa-B ligand (RANKL) in neoplasms time in dogs with stage III osteosarcoma that undergo treatment;90
of dogs and cats, J Vet Intern Med 21:133–140, 2007. cases (1985-2004), J Am Vet Med Assoc 228:1905–1908, 2006.
VetBooks.ir 93. Lana SE, Ogilvie GK, Hansen RA, et al.: Identification of matrix 115. Giuliano AE, Feig S, Eilber FR: Changing metastatic patterns of
osteosarcoma, Cancer 54:2160–2164, 1984.
metalloproteinases in canine neoplastic tissue, Am J Vet Res 61:111–
114, 2000.
94. Schmit JM, Pondenis HC, Barger AM, et al.: Cathepsin K expres- 116. Bacci G, Avella M, Picci P, et al.: Metastatic patterns in osteosar-
coma, Tumori 74:421–427, 1988.
sion and activity in canine osteosarcoma, J Vet Intern Med 26:126– 117. Moore GE, Mathey WS, Eggers JS, et al.: Osteosarcoma in adjacent
134, 2012. lumbar vertebrae in a dog, J Am Vet Med Assoc 217(1008):1038–
95. Marley K, Bracha S, Seguin B: Osteoprotegerin activates osteo- 1040, 2000.
sarcoma cells that co-express RANK and RANKL, Exp Cell Res 118. Talbott JL, Boston SE, Milner RJ, et al.: Retrospective evaluation of
338:32–38, 2015. whole body computed tomography for tumor staging in dogs with
96. Neumann ZL, Pondenis HC, Masyr A, et al.: The association of primary appendicular osteosarcoma, Vet Surg 46:75–80, 2017.
endothelin-1 signaling with bone alkaline phosphatase expression 119. Oblak ML, Boston SE, Woods JP, et al.: Comparison of concurrent
and protumorigenic activities in canine osteosarcoma, J Vet Intern imaging modalities for staging of dogs with appendicular primary
Med 29:1584–1594, 2015. bone tumours, Vet Comp Oncol 13:28–39, 2015.
97. Shor S, Fadl-Alla BA, Pondenis HC, et al.: Expression of nociceptive 120. Sivacolundhu RK, Runge JJ, Donovan TA, et al.: Ulnar osteosar-
ligands in canine osteosarcoma, J Vet Intern Med 29:268–275, 2015. coma in dogs;30 cases (1992-2008), J Am Vet Med Assoc 243:96–
98. Khanna C, Wan X, Bose S, et al.: The membrane-cytoskeleton 101, 2013.
linker ezrin is necessary for osteosarcoma metastasis, Nat Med 121. Montinaro V, Boston SE, Buracco P, et al.: Clinical outcome of
10:182–186, 2004. 42 dogs with scapular tumors treated by scapulectomy;a Veterinary
99. Fan TM, Barger AM, Fredrickson RL, et al.: Investigating CXCR4 Society of Surgical Oncology (VSSO) retrospective study (1995-
expression in canine appendicular osteosarcoma, J Vet Intern Med 2010), Vet Surg 42:943–950, 2013.
22:602–608, 2008. 122. Straw RC, Powers BE, Klausner J, et al.: Canine mandibular osteo-
100. Byrum ML, Pondenis HC, Fredrickson RL, et al.: Downregulation sarcoma; 51 cases (1980-1992), J Am Anim Hosp Assoc 32:257–262,
of CXCR4 expression and functionality after zoledronate exposure 1996.
in canine osteosarcoma, J Vet Intern Med 30:1187–1196, 2016. 123. Dickerson ME, Page RL, LaDue TA, et al.: Retrospective analysis
101. Barger A, Graca R, Bailey K, et al.: Use of alkaline phosphatase of axial skeleton osteosarcoma in 22 large-breed dogs, J Vet Intern
staining to differentiate canine osteosarcoma from other vimentin- Med 15:120–124, 2001.
positive tumors, Vet Pathol 42:161–165, 2005. 124. Selmic LE, Lafferty MH, Kamstock DA, et al.: Outcome and
102. Neihaus SA, Locke JE, Barger AM, et al.: A novel method of core prognostic factors for osteosarcoma of the maxilla, mandible, or
aspirate cytology compared to fine-needle aspiration for diagnosing calvarium in dogs; 183 cases (1986-2012), J Am Vet Med Assoc
canine osteosarcoma, J Am Anim Hosp Assoc 47:317–323, 2011. 245:930–938, 2014.
103. Britt T, Clifford C, Barger A, et al.: Diagnosing appendicular osteo- 125. Coyle VJ, Rassnick KM, Borst LB, et al.: Biological behaviour of
sarcoma with ultrasound-guided fine-needle aspiration; 36 cases, canine mandibular osteosarcoma. A retrospective study of 50 cases
J Small Anim Pract 48:145–150, 2007. (1999-2007), Vet Comp Oncol 13:89–97, 2015.
104. Kirpensteijn J, Kik M, Rutteman GR, et al.: Prognostic significance 126. Amsellem PM, Selmic LE, Wypij JM, et al.: Appendicular osteo-
of a new histologic grading system for canine osteosarcoma, Vet sarcoma in small-breed dogs; 51 cases (1986-2011), J Am Vet Med
Pathol 39:240–246, 2002. Assoc 245:203–210, 2014.
105. Schott CR, Tatiersky LJ, Foster RA, et al.: Histologic grade does 127. Boulay JP, Wallace LJ, Lipowitz AJ: Pathological fracture of long
not predict outcome in dogs with appendicular osteosarcoma bones in the dog, J Am An Hosp Assoc 23:297–303, 1987.
receiving the standard of care, Vet Pathol 55:202–211, 2018. 128. Mazzaferro EM, Hackett TB, Stein TP, et al.: Metabolic alterations
106. O’Donoghue LE, Ptitsyn AA, Kamstock DA, et al.: Expression in dogs with osteosarcoma, Am J Vet Res 62:1234–1239, 2001.
profiling in canine osteosarcoma; identification of biomarkers and 129. Story AL, Boston SE, Kilkenny JJ, et al.: Evaluation of weight
pathways associated with outcome, BMC Cancer 10:506, 2010. change during carboplatin therapy in dogs with appendicular
107. Bhandal J, Boston SE: Pathologic fracture in dogs with suspected or osteosarcoma, J Vet Intern Med 31:1159–1162, 2017.
confirmed osteosarcoma, Vet Surg 40:423–430, 2011. 130. Kazmierski KJ, Ogilvie GK, Fettman MJ, et al.: Serum zinc, chro-
108. Kim MS, Lee SY, Lee TR, et al.: Prognostic effect of pathologic mium, and iron concentrations in dogs with lymphoma and osteo-
fracture in localized osteosarcoma; a cohort/case controlled study at sarcoma, J Vet Intern Med 15:585–588, 2001.
a single institute, J Surg Oncol 100:233–239, 2009. 131. Wrigley RH: Malignant versus nonmalignant bone disease, Vet Clin
109. Ebeid W, Amin S, Abdelmegid A: Limb salvage management of North Am Small Anim Pract 30:315–347, 2000. vi-vii.
pathologic fractures of primary malignant bone tumors, Cancer 132. Charney VA, Miller MA, Heng HG, et al.: Skeletal metastasis
Control 12:57–61, 2005. of canine urothelial carcinoma; pathologic and computed tomo-
110. Bacci G, Ferrari S, Longhi A, et al.: Nonmetastatic osteosarcoma graphic features, Vet Pathol 54:380–386, 2017.
of the extremity with pathologic fracture at presentation;local and 133. Reinhardt S, Stockhaus C, Teske E, et al.: Assessment of cytological
systemic control by amputation or limb salvage after preoperative criteria for diagnosing osteosarcoma in dogs, J Small Anim Pract
chemotherapy, Acta Orthop Scand 74:449–454, 2003. 46:65–70, 2005.
111. Boston SE, Vinayak A, Lu X, et al.: Outcome and complications in 134. Samii VF, Nyland TG, Werner LL, et al.: Ultrasound-guided fine-
dogs with appendicular primary bone tumors treated with stereo- needle aspiration biopsy of bone lesions; a preliminary report, Vet
tactic radiotherapy and concurrent surgical stabilization, Vet Surg Radiol Ultrasound 40:82–86, 1999.
46:829–837, 2017. 135. Ehrhart N: Principles of tumor biopsy, Clin Tech Small Anim Pract
112. Covey JL, Farese JP, Bacon NJ, et al.: Stereotactic radiosurgery and 13:10–16, 1998.
fracture fixation in 6 dogs with appendicular osteosarcoma, Vet 136. Mankin HJ, Lange TA, Spanier SS: The hazards of biopsy in
Surg 43:174–181, 2014. patients with malignant primary bone and soft-tissue tumors,
113. Hillers KR, Dernell WS, Lafferty MH, et al.: Incidence and prog- J Bone Joint Surg Am 64:1121–1127, 1982.
nostic importance of lymph node metastases in dogs with appen- 137. de Santos LA, Murray JA, Ayala AG: The value of percutaneous
dicular osteosarcoma; 228 cases (1986-2003), J Am Vet Med Assoc needle biopsy in the management of primary bone tumors, Cancer
226:1364–1367, 2005. 43:735–744, 1979.